期刊文献+

重症监护患者肝素诱导的血小板减少症 被引量:1

下载PDF
导出
机构地区 解放军总医院
出处 《人民军医》 2008年第6期392-393,共2页 People's Military Surgeon
  • 相关文献

参考文献10

  • 1Pouplard C, May MA, Regina S,et al. Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies[J]. Br J Haematol, 2005,128:837-841.
  • 2Warkentin TE, Greinacher A. Heparininduced thrombocytopenia: Recognition, treatment, and prevention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy[J]. Chest, 2004, 126:311-337.
  • 3Greinacher A, Farner B, Kroll H, et al. Clinical features of heparininduced thrombocytopenia induding risk factors for thrombosis: A retrospective analysis of 408 patients[J]. Thromb Haemost, 2005,94: 132-135.
  • 4Warkentin TE, Heddle NM. Laboratory diagnosis of immune heparininduced thrombocytopenia[J]. Curr Hematol Rep, 2003,2:148-157.
  • 5Kathleen S, Theodore EW,Andreas O. Heparin-induced thrombocytopenia in intensive care patients [J]. Crit Care Med, 2007, 35: 1165-1176.
  • 6Chong BH, Magnani HN. Danaparoid for the treatment of heparin-induced thrombocytopenia [A]. In: Warkentin TE, Greinacher A Eds. Heparin-Induced Thrombocytopenia [M]. Third Edition. New York, Marcel Dekker, 2004:371-398.
  • 7Greinacher A. Lepirudin: A bivalent directthrombin inhibitor for anticoagulation therapy [J]. Expert Rev Cardiovasc Ther, 2004, 2: 339-357.
  • 8Reichert MG, MacGregor DA, Kincaid EH, et al. Excessive argatroban anticoagulation for heparin-induced thrombocytopenia[J]. Ann Pharmacother, 2003,37 : 652-654.
  • 9Levine RL, Hursting MJ, McCollum D. Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction [J]. Chest 2006,129 : 1167-1175.
  • 10Warkentin TE. Should vitamin K be administered when HIT is diagnosed after administration of coumarin[J]. Thromb Haemost,2006,4: 894-896.

同被引文献15

  • 1翟晓文,吴玥.败血症和血小板减少[J].中国小儿急救医学,2006,13(3):283-284. 被引量:6
  • 2成人严重感染与感染性休克血流动力学监测与支持指南[J].中华内科杂志,2007,46(4):344-349. 被引量:91
  • 3Levi M. The coagulant response in sepsis and inflammation[J].Hamost Aseologie,2010,30( 1):10-16.
  • 4Levi M, Van der Poll T, Ten Cate H, et al. The cytokine-mediated imbalance between coagulation and anticoagulantmechanisms in sepsis and endotoxemia[J]. Eur J ClinInvest,1997,27(1):3-9.
  • 5Schouten M, Wiersinga WJ, Lervi M, et al. Inflammation,endothelium, and coagulation in sepsis[J]. LeukocBiol,2008,83(3):536-545.
  • 6Levi M, Schouten M. Coagulation and platelet disorders in criticallyill patients[J]. Minerva- Anestesiol,2010,76(l 0):851-859.
  • 7HuiP, Cook DJ, Lim W, et al. The frequency and clinicalsignificance of thrombocytopenia complicating criticalillness: a systematic review[J]. Chest,2011,139(2):271-278.
  • 8章志丹.全身性感染炎症与凝血的交互作用[D].重症医学——2011 会议纪要,2011(R459.7):339-344.
  • 9Vandijck DM,Donahoe L, Clarke FJ,et al. Risk markersfor thromboytopenia in critically ill patients: a prospectiveanalysis[J]. Pharmacotherapy,2002,22(7):803-813.
  • 10Oguzulgen IK, Ozis T, Gursel G. Is the fall in platelet countassociated with intensive care unit acquired pneumonia.[J].Swiss Med Wkly,2004,134(29-30):430-434.

引证文献1

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部